NATALIA MORRIS: Open Payments
NPI 1467708545 · LA QUINTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 32 payments from 6 companies in 2025. Trend: 2023 $196 · 2024 $725 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $396 |
| Ardelyx, Inc. | 4 | $107 |
| Janssen Biotech, Inc. | 2 | $73 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| GENZYME CORPORATION | 1 | $33 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: LINZESS, RINVOQ, CREON, IBSRELA, TREMFYA, DUPIXENT, VIBERZI, SKYRIZI.
Industry payments across CA — which companies pay providers there.
